Publications by authors named "Pietro Morrone"

Claim this Profile
U
Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.
Eustachio Nettis, Mattia Cristallo, Carmen S Fiorella, Angela Giuliani, Vincenzo Patella, Pietro Morrone

Ital J Dermatol Venerol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study.
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, Michela Ortoncelli, Simone Ribero, Pietro Morrone

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases.
Pietro Morrone, Francesca Caroppo, Alberto De Pedrini, Alessandro Colletti, Germano Baj

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, Michela Ortoncelli, Simone Ribero, Pietro Morrone

Int J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.
Alessandra Narcisi, Vito Di Lernia, Maria Esposito, Vittorio Forte, Silvia Mariel Ferrucci, Pietro Morrone

Dermatol Ther (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Matteo Megna, Diego Orsini, Chiara Assorgi, Anna Balato, Riccardo Balestri, Pietro Morrone

Clin Exp Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel.
Annamaria Offidani, Angelo Valerio Marzano, Ketty Peris, Elisa Molinelli, Vincenzo Bettoli, Pietro Morrone

Dermatology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Luigi Gargiulo, Luciano Ibba, Angela Alfano, Piergiorgio Malagoli, Fabrizio Amoruso, Pietro Morrone

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, Laura Atzori, Anna Balato, Pietro Morrone

Dermatol Ther (Heidelb)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, Mario Bruno Guanti, Donatella Schena, Pietro Morrone

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis suppurativa and psoriasis: the odd couple.
Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Pietro Morrone, Gianluca Trifirò

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine in Managing Skin Conditions: A Systematic Review.
Stefano Dastoli, Steven Paul Nisticò, Pietro Morrone, Cataldo Patruno, Antonio Leo

Pharmaceutics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Luigi Bennardo, Francesco Bennardo, Amerigo Giudice, Maria Passante, Stefano Dastoli, Pietro Morrone

Curr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment with omalizumab of a patient with spontaneous chronic urticaria and eosinophilic esophagitis.
Eugenio Provenzano, Pietro Morrone

J Dermatolog Treat· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel-cell carcinoma in Behçet's disease.
Francesca Satolli, Caterina Venturi, Veronica Vescovi, Pietro Morrone, Giuseppe De Panfilis

Acta Derm Venereol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis